Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Corsini

Showing results (81-90 of 200) with videos related to

Pageof 20
Sort By:
International Journal of Molecular Sciences|September 7, 2019
Impact of PPAR-Alpha Polymorphisms-The Case of Metabolic Disorders and AtherosclerosisMassimiliano Ruscica, Marco Busnelli, Enrico Runfola, et al.
Pharmacology & Therapeutics|March 20, 2013
Drug attrition during pre-clinical and clinical development: understanding and managing drug-induced cardiotoxicityNicola Ferri, Peter Siegl, Alberto Corsini, et al.
Seminars in Thrombosis and Hemostasis|May 12, 2026
Hemostatic Aspects of Interactions Between Anticancer Drugs and Oral Anticoagulants in Patients with Cancer-Associated Venous ThromboembolismAntonella Tufano, Alberto Corsini, Anna Guida, et al.
Pharmacological Research|August 27, 2021
Lipoprotein(a): Knowns, unknowns and uncertaintiesMassimiliano Ruscica, Cesare R Sirtori, Alberto Corsini, et al.
Pharmacological Research|July 7, 2022
Omega-3 and cardiovascular prevention - Is this still a choice?Massimiliano Ruscica, Cesare R Sirtori, Stefano Carugo, et al.
Pharmacological Research|July 21, 2016
Pharmacokinetics interactions of monoclonal antibodiesNicola Ferri, Stefano Bellosta, Ludovico Baldessin, et al.
Environment International|April 29, 2023
Pollution from fine particulate matter and atherosclerosis: A narrative reviewChiara Macchi, Cesare R Sirtori, Alberto Corsini, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|March 4, 2026
Challenges and Perspectives in Optimising the Treatment of Arterial Hypertension: Role of the Ramipril-Amlodipine-Hydrochlorothiazide Single-Pill CombinationMaria Lorenza Muiesan, Aldo Pietro Maggioni, Roberto Pontremoli, et al.
Current Atherosclerosis Reports|March 11, 2021
Lipid Lowering Drugs: Present Status and Future DevelopmentsMassimiliano Ruscica, Nicola Ferri, Raul D Santos, et al.
Atherosclerosis|December 7, 2010
Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) by 15-lipoxygenase-modified LDL in endothelial cellsAngela Pirillo, Alice Reduzzi, Nicola Ferri, et al.
Pageof 20

Showing results (81-90 of 200) with videos related to

Sort By:
Pageof 20
International Journal of Molecular Sciences|September 7, 2019
Impact of PPAR-Alpha Polymorphisms-The Case of Metabolic Disorders and AtherosclerosisMassimiliano Ruscica, Marco Busnelli, Enrico Runfola, et al.
Pharmacology & Therapeutics|March 20, 2013
Drug attrition during pre-clinical and clinical development: understanding and managing drug-induced cardiotoxicityNicola Ferri, Peter Siegl, Alberto Corsini, et al.
Seminars in Thrombosis and Hemostasis|May 12, 2026
Hemostatic Aspects of Interactions Between Anticancer Drugs and Oral Anticoagulants in Patients with Cancer-Associated Venous ThromboembolismAntonella Tufano, Alberto Corsini, Anna Guida, et al.
Pharmacological Research|August 27, 2021
Lipoprotein(a): Knowns, unknowns and uncertaintiesMassimiliano Ruscica, Cesare R Sirtori, Alberto Corsini, et al.
Pharmacological Research|July 7, 2022
Omega-3 and cardiovascular prevention - Is this still a choice?Massimiliano Ruscica, Cesare R Sirtori, Stefano Carugo, et al.
Pharmacological Research|July 21, 2016
Pharmacokinetics interactions of monoclonal antibodiesNicola Ferri, Stefano Bellosta, Ludovico Baldessin, et al.
Environment International|April 29, 2023
Pollution from fine particulate matter and atherosclerosis: A narrative reviewChiara Macchi, Cesare R Sirtori, Alberto Corsini, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|March 4, 2026
Challenges and Perspectives in Optimising the Treatment of Arterial Hypertension: Role of the Ramipril-Amlodipine-Hydrochlorothiazide Single-Pill CombinationMaria Lorenza Muiesan, Aldo Pietro Maggioni, Roberto Pontremoli, et al.
Current Atherosclerosis Reports|March 11, 2021
Lipid Lowering Drugs: Present Status and Future DevelopmentsMassimiliano Ruscica, Nicola Ferri, Raul D Santos, et al.
Atherosclerosis|December 7, 2010
Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) by 15-lipoxygenase-modified LDL in endothelial cellsAngela Pirillo, Alice Reduzzi, Nicola Ferri, et al.
Pageof 20